AGITG Trial news: The AGITG currently has nine studies open to recruitment and seven studies in follow up.
The table below details the AGITG trials that are currently accruing patients.
| Recruited | Target | Recruitment Period (months) | Date of First Site Open (ANZ) | Number of Sites Open | |
| DYNAMIC-III (Colon cancer) | 653 | 1000 | 54 | 09 October 2017 | 42 |
| DYNAMIC-Pancreas (Pancreatic cancer) | 98 | 438 | 54 | 01 March 2019 | 26 |
| GENESCREEN 5-FU (Pan Tumour) | 41 | 50 | 50 | 1 February 2021 | 2 |
| INTEGRATE IIb (Gastro-oesophageal cancer) | 60 | 450 | 24 | 28 April 2021 | 24 |
| LICPIC (Colorectal cancer) | 62 | 100 | 110 | 11 September 2018 | 2 |
| MASTERPLAN (Pancreatic cancer) | 20 | 120 | 48 | 01 October 2019 | 11 |
| NABNEC (Neuroendocrine tumours) | 59 | 58 | 54 | 15 September 2016 | 18 |
| OXTOX (Colorectal cancer) | 8 | 100 | 18 | 18 December 2020 | 7 |
| PALEO (Oesophageal cancer) | 5 | 54 | 36 | 16 September 2019 | 1 |
| RANDOMS (Pancreatic cancer) | 7 | 60 | 38 | 14 December 2020 | 3 |
| RENO (Rectal cancer) | 47 | 125 | 36 | 21 January 2019 | 7 |
| RoLaCaRT-1 (Colorectal Cancer) | 8 | 50 | 12 | 06 August 2021 | 8 |
| SPAR (Rectal cancer) | 94 | 222 | 48 | 13 April 2018 | 14 |